Avidity Partners Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $580K | Hold |
134,566
| – | – | 0.12% | 52 |
|
|
2025
Q1 | $503K | Sell |
134,566
-1
| -0% | -$4 | 0.1% | 60 |
|
|
2024
Q4 | $1.37M | Hold |
134,567
| – | – | 0.13% | 59 |
|
|
2024
Q3 | $1.68M | Hold |
134,567
| – | – | 0.09% | 78 |
|
|
2024
Q2 | $1.75M | Sell |
134,567
-418,671
| -76% | -$5.45M | 0.07% | 81 |
|
|
2024
Q1 | $12.5M | Hold |
553,238
| – | – | 0.4% | 63 |
|
|
2023
Q4 | $7.18M | Hold |
553,238
| – | – | 0.26% | 62 |
|
|
2023
Q3 | $11.1M | Sell |
553,238
-4,769
| -0.9% | -$95.9K | 0.45% | 64 |
|
|
2023
Q2 | $15M | Sell |
558,007
-84,254
| -13% | -$2.26M | 0.52% | 64 |
|
|
2023
Q1 | $37.5M | Hold |
642,261
| – | – | 1.24% | 32 |
|
|
2022
Q4 | $32.8M | Buy |
+642,261
| New | +$32.8M | 0.71% | 40 |
|